ArticleCureus2025
Massive Cutaneous Xanthomas and Critical Triple-Vessel Coronary Artery Disease From Familial Hypercholesterolemia in a 40-Year-Old Woman.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Familial hypercholesterolemia is a monogenic inherited disorder of lipoprotein metabolism that often remains undiagnosed, primarily due to a lack of awareness rather than its rarity. We report the case of a 40-year-old unmarried woman who presented with worsening symptoms of exertional angina over six months. Physical examination revealed large xanthomas involving the dorsal aspect of both hands and feet and the extensor aspect of both knees and elbows and buttocks and a necklace-like lesion over the neck and upper chest, which had developed since her mid-20s. Her past and family history were suggestive, as her father had succumbed to myocardial infarction at 43 years of age. Laboratory evaluation demonstrated severe hypercholesterolemia with a total cholesterol of 485 mg/dl and low-density lipoprotein cholesterol of 398 mg/dl, with normal triglycerides and high-density lipoprotein cholesterol. Other systemic and metabolic parameters were within normal limits. Cardiovascular evaluation detected a soft systolic murmur, mild calcific aortic valve sclerosis, and mild aortic regurgitation, and duplex ultrasound revealed significant carotid artery stenoses. Coronary angiography demonstrated marked aortic root calcification and critical triple-vessel coronary artery disease. The diagnosis of heterozygous familial hypercholesterolemia was established clinically; genetic analysis could not be performed. The patient was advised to undergo coronary artery bypass grafting and started on high-dose rosuvastatin and ezetimibe, but could not afford proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. This case highlights the challenges in the early diagnosis and effective management of familial hypercholesterolemia, particularly in resource-constrained settings, underscoring the need for physician awareness and family-based screening to prevent premature atherosclerotic cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.